1. Gastrointestinal Stromal Tumor With Chondrosarcomatous Dedifferentiation Following Imatinib Therapy
   Nektarios Koufopoulos et al, 2021, Cureus CrossRef
2. Skeletal muscle metastasis from a gastrointestinal stromal tumor
   Guangsheng Zhu et al, 2021, Medicine CrossRef
3. Heredo-Familial and Pediatric GISTs: Spot the Differences
   Perez Alessandro, 2019, Scientific Journal of Genetics and Gene Therapy CrossRef
4. Using Ion Torrent sequencing to study genetic mutation profiles of fatal thyroid cancers
   Jin-Ying Lu et al, 2018, Journal of the Formosan Medical Association CrossRef
5. Open transanal resection of low rectal stromal tumor following neoadjuvant therapy of imatinib mesylate: Report of 11 cases and review of literature
   Qiang Sun et al, 2020, Asia-Pacific Journal of Clinical Oncology CrossRef
6. Prognostic and predictive values of the KIT11-mutated grading system in patients with gastrointestinal stromal tumors: a retrospective study
   Ling-Jun Song et al, 2021, Human Pathology CrossRef
7. Dedifferentiated gastrointestinal stromal tumor: Recent advances
   Cansu Karakas et al, 2019, Annals of Diagnostic Pathology CrossRef
8. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study
   Jing Qi et al, 2020, World Journal of Surgical Oncology CrossRef
9. Clinicopathological and molecular characteristics of synchronous gastric adenocarcinoma and gastrointestinal stromal tumors
   Jun-Ming Luo et al, 2017, Scientific Reports CrossRef
10. Gastrointestinal Stromal Tumor With Multiple Primary Tyrosine Kinase Mutations—Clinicopathologic and Molecular Characterization
    Newton A.C.S. Wong et al, 2019, Applied Immunohistochemistry & Molecular Morphology CrossRef
11. The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs
    Fabio Gentilini et al, 2020, BMC Veterinary Research CrossRef
12. Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants
    Tsung-Sheng Wu et al, 2019, Journal of Medicinal Chemistry CrossRef
13. Complete response of advanced rectal gastrointestinal stromal tumors after imatinib treatment: A case report and literature review
    Tingting Wu et al, 2022, Medicine CrossRef
14. Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study
    Ruihua Zhao et al, 2023, Frontiers in Oncology CrossRef